DA-Raf1, a competent intrinsic dominant-negative antagonist of the Ras-ERK pathway, is required for myogenic differentiation

Journal of Cell Biology

Volumn 177, Issue 5, 2007, Pages 781-793

  Yokoyama, Takashi ^a,c   Takano, Kazunori ^a,c   Yoshida, Akira ^a   Katada, Fumiko ^a   Sun, Peng ^a,c   Takenawa, Tadaomi ^b,c   Andoh, Toshiwo ^d   Endo, Takeshi ^a,c  

^a CHIBA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d SOKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DA RAF1 PROTEIN; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MYOGENIN; PROTEIN; RAS PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; MOUSE; MYOTUBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; TISSUE DISTRIBUTION;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL CYCLE; CELL DIFFERENTIATION; CELLS, CULTURED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MOLECULAR SEQUENCE DATA; MONOMERIC GTP-BINDING PROTEINS; MUSCLE DEVELOPMENT; MUSCLE FIBERS; MYOGENIN; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS A-RAF; RATS;

EID: 34249880794     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200703195     Document Type: Article

References (58)

1. Abe, H., T. Komiya, and T. Obinata. 1986. Expression of multiple troponin T variants in neonatal chicken breast muscle. Dev. Biol. 118:42-51.
2. Abe, T., M. Kato, H. Miki, T. Takenawa, and T. Endo. 2003. Small GTPase Tc10 and its homologue RhoT induce N-WASP-mediated long process formation and neurite outgrowth. J. Cell Sci. 116:155-168.
3. Barnier, J.V., C. Papin, A. Eychene, O. Lecoq, and G. Calothy. 1995. The mouse B-raf gene encodes multiple protein isoforms with tissue-specific expression. J. Biol. Chem. 270:23381-23389.
4. Bar-Sagi, D., and J.R. Feramisco. 1986. Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. Science. 233:1061-1068.
5. Bennett, A.M., and N.K. Tonks. 1997. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science. 278:1288-1291.
6. Black, B.L., and E.N. Olson. 1998. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 14:167-196.
7. Campbell, S.L., R. Khosravi-Far, K.L. Rossman, G.J. Clark, and C.J. Der. 1998. Increasing complexity of Ras signaling. Oncogene. 17:1395-1413.
8. Chang, L., and M. Karin. 2001. Mammalian MAP kinase signalling cascades. Nature. 410:37-40.
9. Charge, S.B.P., and M.A. Rudnicki. 2004. Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 84:209-238.
10. Chong, H., H.G. Vikis, and K.-L. Guan. 2003. Mechanisms of regulating the Raf kinase family. Cell. Signal. 15:463-469.
11. Clark, G.J., A.D. Cox, S.M. Graham, and C.J. Der. 1995. Biological assays for Ras transformation. Methods Enzymol. 255:395-412.
12. Cowley, S., H. Paterson, P. Kemp, and C.J. Marshall. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell. 77:841-852.
13. Downward, J. 1997. Cell cycle: routine role for Ras. Curr. Biol. 7:R258-R260.
14. Endo, T., and S. Goto. 1992. Retinoblastoma gene product Rb accumulates during myogenic differentiation and is deinduced by the expression of SV40 large T antigen. J. Biochem. (Tokyo). 112:427-430.
15. Endo, T., and B. Nadal-Ginard. 1987. Three types of muscle-specific gene expression in fusion-blocked rat skeletal muscle cells: translational control in EGTA-treated cells. Cell. 49:515-526.
16. Glass, D.J. 2003. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat. Cell Biol. 5:87-90.
17. Hagemann, C., and U.R. Rapp. 1999. Isotype-specific functions of Raf kinases. Exp. Cell Res. 253:34-46.
18. Huleihel, M., M. Goldsborough, J. Cleveland, M. Gunnell, T. Bonner, and U.R. Rapp. 1986. Characterization of murine A-raf, a new oncogene related to the v-raf oncogene. Mol. Cell. Biol. 6:2655-2662.
19. Kim, H.J., and D. Bar-Sagi. 2004. Modulation of signalling by Sprouty: a developing story. Nat. Rev. Mol. Cell Biol. 5:441-450.
20. Kimmelman, A.C., N. Nunez Rodriguez, and A.M.-L. Chan. 2002. R-Ras3/M-Ras induces neuronal differentiation of PC12 cells through cell-type-specific activation of the mitogen-activated protein kinase cascade. Mol. Cell. Biol. 22:5946-5961.
21. Kolch, W., G. Heidecker, P. Lloyd, and U.R. Rapp. 1991. Raf-1 protein kinase is required for growth of induced NIH/3T3 cells. Nature. 349:426-428.
22. Lassar, A.B., M.J. Thayer, R.W. Overell, and H. Weintraub. 1989. Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1. Cell. 58:659-667.
23. Lassar, A.B., S.X. Skapek, and B. Novitch. 1994. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell Biol. 6:788-794.
24. Lee, K.Y., M.H. Ladha, C. McMahon, and M.E. Ewen. 1999. The retinoblastoma protein is linked to the activation of Ras. Mol. Cell. Biol. 19:7724-7732.
25. Mansour, S.J., W.T. Matten, A.S. Hermann, J.M. Candia, S. Rong, K. Fukasawa, G.F. Vande Woude, and N.G. Ahn. 1994. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science. 265:966-970.
26. Marshall, C.J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 80:179-185.
27. Mason, J.M., D.J. Morrison, M.A. Basson, and J.D. Licht. 2006. Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. Trends Cell Biol. 16:45-54.
28. Matheny, S.A., C. Chen, R.L. Kortum, G.L. Razidlo, R.E. Lewis, and M.A. White. 2004. Ras regulates assembly of mitogenic signalling complexes through the effector protein IMP. Nature. 427:256-260.
29. Matsumoto, K., T. Asano, and T. Endo. 1997. Novel small GTPase M-Ras participates in reorganization of actin cytoskeleton. Oncogene. 15:2409-2417.
30. Mercer, K.E., and C.A. Pritchard. 2003. Raf proteins and cancer: B-Raf is identified as a mutational target. Biochim. Biophys. Acta. 1653:25-40.
31. Mitin, N., K.L. Rossman, and C.J. Der. 2005. Signaling interplay in Ras super-family function. Curr. Biol. 15:R563-R574.
32. Mittnacht, S., H. Paterson, M.F. Olson, and C.J. Marshall. 1997. Ras signalling is required for inactivation of the tumour suppressor pRb cell-cycle control protein. Curr. Biol. 7:219-221.
33. 2 phases of the cell cycle. J. Cell Biol. 135:441-456.
34. Novitch, B.G., D.B. Spicer, P.S. Kim, W.L. Cheung, and A.B. Lassar. 1999. pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation. Curr. Biol. 9:449-459.
35. Odabaei, G., D. Chatterjee, A.R. Jazirehi, L. Goodglick, K. Yeung, and B. Bonavida. 2004. Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosis. Adv. Cancer Res. 91:169-200.
36. Olson, E.N., G. Spizz, and M.A. Tainsky. 1987. The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation. Mol. Cell. Biol. 7:2104-2111.
37. Ory, S., and D.K. Morrison. 2004. Signal transduction: implications for Ras-dependent ERK signaling. Curr. Biol. 14:R277-R278.
38. Papin, C., A. Denouel-Galy, D. Laugier, G. Calothy, and A. Eychene. 1998. Modulation of kinase activity and oncogenic properties by alternative splicing reveals a novel regulatory mechanism for B-Raf. J. Biol. Chem. 273:24939-24947.
39. Pearson, G., F. Robinson, T.B. Gibson, B. Xu, M. Karandikar, K. Berman, and M.H. Cobb. 2001. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22:153-183.
40. Peeper, D.S., T.M. Upton, M.H. Ladha, E. Neuman, J. Zalvide, R. Bernards, J.A. DeCaprio, and M.E. Ewen. 1997. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature. 386:177-181.
41. Perry, R.L.S., M.H. Parker, and M.A. Rudnicki. 2001. Activated MEK1 binds the nuclear MyoD transcriptional complex to repress transactivation. Mol. Cell. 8:291-301.
42. Quilliam, L.A., A.F. Castro, K.S. Rogers-Graham, C.B. Martin, C.J. Der, and C. Bi. 1999. M-Ras/R-Ras3, a transforming Ras protein regulated by Sos1, GRF1, and p120 Ras GTPase-activating protein, interacts with the putative Ras effector AF6. J. Biol. Chem. 274:23850-23857.
43. Rodriguez-Viciana, P., P.H. Warne, A. Khwaja, B.M. Marte, D. Pappin, P. Das, M.D. Waterfield, A. Ridley, and J. Downward. 1997. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell. 89:457-467.
44. Rommel, C., B.A. Clarke, S. Zimmermann, L. Nunez, R. Rossman, K. Reid, K. Moelling, G.D. Yancopoulos, and D.J. Glass. 1999. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science. 286:1738-1741.
45. Schaeffer, H.J., and M.J. Weber. 1999. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19:2435-2444.
46. -/- muscle cells. Science. 264:1467-1471.
47. Schramek, H. 2002. MAP kinases: from intracellular signals to physiology and disease. News Physiol. Sci. 17:62-67.
48. Sun, P., H. Watanabe, K. Takano, T. Yokoyama, J. Fujisawa, and T. Endo. 2006. Sustained activation of M-Ras induced by nerve growth factor is essential for neuronal differentiation of PC12 cells. Genes Cells. 11:1097-1113.
49. Tapscott, S.J. 2005. The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development. 132:2685-2695.
50. Tortorella, L.L., D.J. Milasincic, and P.F. Pilch. 2001. Critical proliferation-independent window for basic fibroblast growth factor repression of myogenesis via the p42/p44 MAPK signaling pathway. J. Biol. Chem. 276:13709-13717.
51. Vetter, I.R., and A. Wittinghofer. 2001. The guanine nucleotide-binding switch in three dimensions. Science. 294:1299-1304.
52. Voice, J.K., R.L. Klemke, A. Le, and J.H. Jackson. 1999. Four human Ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility. J. Biol. Chem. 274:17164-17170.
53. Wakioka, T., A. Sasaki, R. Kato, T. Shouda, A. Matsumoto, K. Miyoshi, M. Tsuneoka, S. Komiya, R. Baron, and A. Yoshimura. 2001. Spred is a Sprouty-related suppressor of Ras signalling. Nature. 412:647-651.
54. Wellbrock, C., M. Karasarides, and R. Marais. 2004. The RAF proteins take centre stage. Nat. Rev. Mol. Cell Biol. 5:875-885.
55. Winter, B., and H.-H. Arnold. 2000. Activated Raf kinase inhibits muscle cell differentiation through a MEF2-dependent mechanism. J. Cell Sci. 113:4211-4220.
56. Yan, J., S. Roy, A. Apolloni, A. Lane, and J.F. Hancock. 1998. Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. J. Biol. Chem. 273:24052-24056.
57. Yeung, K., T. Seitz, S. Li, P. Janosch, B. McFerran, C. Kaiser, F. Fee, K.D. Katsanakis, D.W. Rose, H. Mischak, et al. 1999. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature. 401:173-177.
58. Yuryev, A., M. Ono, S.A. Goff, F. Macaluso, and L.P. Wennogle. 2000. Isoform-specific localization of A-RAF in mitochondria. Mol. Cell. Biol. 20:4870-4878.